The transgene consists of a 1.7 kb enhancer of Atoh1 and beta-globin minimal promotor followed by CreERT2-SV40pA. One founder (#45) shows cre activity in absence of tamoxifen was established. (J:306314)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count